Home Itens selecionados Provedores de dados OAI Créditos Sobre Ajuda

			Busca avançada
	Provedor de dados ArchiMer (1) BJPS (1) Autor Monteiro,Gisele (1) Moreau, Dimitri (1) Sousa,Graziele Fonseca de (1) Wlodarczyk,Samarina Rodrigues (1) Palavra-chave Molecular targets (2) ARN régulateur (1) Antiproliferativ (1) Antiprolifératif (1) Antitumors/platinum-based (1) Apoptose (1) Apoptosis (1) Bronchopulmonary cancer (1) Cancer bronchopulmonaire (1) Carboplatin/mechanisms of resistance (1) Cibles moléculaires (1) Cisplatin/mechanisms of resistance (1) Drugs/resistance (1) Expression génique (1) Gene expression (1) Microalgae (1) Microalgues (1) Molécules naturelles (1) Natural products (1) Regulatory RNA (1) Mais... Tipo do documento Info:eu-repo/semantics/article (1) Text (1) Ano 2014 (1) 2006 (1) País Brazil (1) France (1) Idioma Francês (1) Inglês (1)		Ordenar por:  Relevância Autor Título Ano Registros recuperados: 2 Primeira ... 1 ... Última Carboplatin: molecular mechanisms of action associated with chemoresistance BJPS Sousa,Graziele Fonseca de; Wlodarczyk,Samarina Rodrigues; Monteiro,Gisele. Carboplatin is a derivative of cisplatin; it has a similar mechanism of action, but differs in terms of structure and toxicity. It was approved by the FDA in the 1980s and since then it has been widely used in the treatment of several tumor types. This agent is characterized by its ability to generate lesions in DNA through the formation of adducts with platinum, thereby inhibiting replication and transcription and leading to cell death. However, its use can lead to serious inconvenience arising from the development of resistance that some patients acquire during treatment, limiting the scope of its full potential. Currently, the biochemical mechanisms related to resistance are not precisely known. Therefore, knowledge of pathways associated with... Tipo: Info:eu-repo/semantics/article Palavras-chave: Carboplatin/mechanisms of resistance; Cisplatin/mechanisms of resistance; Drugs/resistance; Molecular targets; Antitumors/platinum-based. Ano: 2014 URL: http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502014000400693 Etude de nouvelles cibles moleculaires de cancer bronchopulmonaire non a petites cellules pharmacomodulées par des substances originales naturelles et synthetiques ArchiMer Moreau, Dimitri. Still rare disease at the beginning of the 20th century, the lung cancer is at the origin of more than 6 % of the deaths in France currently. It occupies there the first rank of the deaths by cancer whereas France is regarded as a country at the average risk among the Western countries. The discovery of new anti-cancer treatments increasingly more effective and specific, is thus today of primary importance. The validation of the capacity of a molecule to being able to inhibit the cancerous proliferation, passes by several stages of tests starting with the description of an activity at the cellular level. One of the strategies used for the discovery of new compounds antiproliferativs, passes by an investigation of the bioactiv potential of a great number... Tipo: Text Palavras-chave: Microalgae; Natural products; Apoptosis; Antiproliferativ; Gene expression; Regulatory RNA; Molecular targets; Bronchopulmonary cancer; Microalgues; Molécules naturelles; Apoptose; Antiprolifératif; Expression génique; ARN régulateur; Cibles moléculaires; Cancer bronchopulmonaire. Ano: 2006 URL: http://archimer.ifremer.fr/doc/2006/these-2196.pdf Registros recuperados: 2 Primeira ... 1 ... Última

Empresa Brasileira de Pesquisa Agropecuária - Embrapa Todos os direitos reservados, conforme Lei n° 9.610 Política de Privacidade Área restrita		Embrapa Parque Estação Biológica - PqEB s/n° Brasília, DF - Brasil - CEP 70770-901 Fone: (61) 3448-4433 - Fax: (61) 3448-4890 / 3448-4891 SAC: https://www.embrapa.br/fale-conosco